How long after switching from Ryeqo (likely referring to a hormonal contraceptive, possibly a typo) to Mirena (levonorgestrel-releasing intrauterine system) does diffuse alopecia resolve?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Resolution Timeline for Diffuse Alopecia After Switching from Ryeqo to Mirena

Direct Answer

Diffuse alopecia related to hormonal contraceptive changes typically begins to improve within 2-3 months after discontinuing the causative agent, with hair regrowth occurring at approximately 1 cm per month, though complete resolution may take 6-12 months or longer. 1

Understanding the Hair Growth Timeline

The resolution of hormone-related diffuse alopecia follows the natural hair cycle physiology:

  • Initial regrowth begins: 2-3 months after removing the hormonal trigger, as damaged hair follicles transition from telogen (resting) phase back to anagen (growth) phase 1
  • Visible improvement: Typically noticeable at 3-6 months as new hair reaches sufficient length 1
  • Hair growth rate: Approximately 1 cm per month once active growth resumes 1
  • Complete resolution: May require 6-18 months depending on severity and individual factors 1, 2

Key Factors Affecting Recovery

Severity and pattern matter significantly:

  • Diffuse alopecia (more common with systemic hormonal changes) generally shows more uniform recovery compared to patchy patterns 1, 2
  • Grade 2 alopecia (>50% hair loss) takes longer to resolve than grade 1 1, 2
  • Endocrine therapy-induced alopecia typically presents with crown and frontal/bitemporal recession patterns 1

Important Clinical Considerations

Before attributing alopecia solely to the medication switch, rule out other causes:

  • Check thyroid function (TSH, free T4) 1
  • Assess iron stores (ferritin) 1
  • Evaluate vitamin D and zinc levels 1
  • Consider female-pattern hair loss, alopecia areata, or inflammatory scarring alopecia as differential diagnoses 1

The Mirena IUD itself has low systemic hormonal effects and is unlikely to perpetuate alopecia, as the levonorgestrel is primarily locally active in the uterus 1. This makes it a reasonable alternative for patients experiencing hair loss from systemic hormonal contraceptives 3.

Treatment Options to Accelerate Recovery

While waiting for natural resolution, consider:

  • Topical minoxidil: First-line treatment showing moderate to significant improvement in 67-76% of patients with hormone-related alopecia 2
  • Oral spironolactone: Alternative or adjunctive therapy, particularly for androgenic patterns 2
  • Laboratory correction: Address any identified deficiencies (iron, vitamin D, zinc) 1

Critical Pitfall to Avoid

Do not assume immediate resolution upon switching contraceptives. The hair follicles that were pushed into telogen phase by the previous medication need time to complete their cycle and re-enter active growth 1. Patients should be counseled that improvement is gradual and requires patience, as premature discontinuation of the new method or unnecessary treatment changes can complicate management 1, 2.

Realistic Patient Expectations

Approximately 65% of patients report changes in hair color and texture when hair regrows after hormonal disruption 1. The new hair may initially appear finer or different in quality before normalizing over subsequent months 1.

If no improvement is seen by 6 months, or if hair loss worsens, reassess for alternative diagnoses or consider referral to dermatology for further evaluation and potential treatment with more aggressive therapies 1, 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Alopecia due to high androgen index contraceptives.

JAAPA : official journal of the American Academy of Physician Assistants, 2018

Research

Treatment of alopecia areata: An Australian expert consensus statement.

The Australasian journal of dermatology, 2019

Research

Hair Loss: Diagnosis and Treatment.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.